SNP China Petroleum and Chemical Corp

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

Koios Beverage Corp., formerly Super Nova Petroleum Corp. (CSE:SNP) (OTC:SNOVF) (the “Company” or “Koios Bev”), is pleased to announce it has changed its name from “Super Nova Petroleum Corp.” to “Koios Beverage Corp.” It is expected that the common shares of the Company will be listed under the symbol “KBEV” once the Canadian Securities Exchange (the “CSE”) provides final approval following the completion of the “fundamental change” transaction described below, and all final conditions of the CSE are satisfied such that the CSE publishes a final bulletin to announce the resumption of trading of the common shares of the Company. The CUSIP number assigned to the Company’s common shares under its new name is 500271101.

The Company and Koios, Inc. (formerly Koios, LLC) (“Koios”) continue to work towards completion of the previously announced acquisition by the Company of all the issued and outstanding securities of Koios and related matters which will constitute a “fundamental change” for Koios Bev under the policies of the CSE. For additional information on the transaction, please see the Company’s news release dated October 23, 2017, which is available on SEDAR at www.sedar.com.

About Koios

Koios in an emerging functional beverage company which has an available distribution network of over 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well.  Together these distributors represent over 80,000 brick and mortar locations across the United States from sports nutrition stores to large natural grocery chains including Whole Foods and Sunflower markets.  Through its partnership with Wishing-U-Well, Koios also enjoys a large presence online, including being an Amazon choice product.  

Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.  

Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity.  Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.  

Koios is one of the only drinks in the world to infuse its products with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity.  

On behalf of the Board of Directors of the Company.

KOIOS BEVERAGE CORP.

“Wolf Wiese” Wolf Wiese, President & CEO

For further information, please contact: 

Corporate Communications 604-221-8936

Completion of the transaction is subject to a number of conditions, including CSE acceptance. There can be no assurance that the transaction will be completed as proposed or at all.

Investors are cautioned that any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of Koios Bev should be considered highly speculative.

Forward-Looking Statements

This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: the closing of the transaction, the listing of the Company’s shares under the symbol KBEV and timing for resumption of trading for the Company’s shares. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements.

Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include, among other things: that the CSE or the Company’s shareholders may not approve the transaction as proposed or at all; that the parties may not be able to satisfy the conditions to closing of the transaction; general market conditions; and other factors beyond the control of the parties. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

Koios has not conducted any scientific studies on the effects of Koios’ products which have been evaluated by Health Canada or the U.S. Food and Drug Administration.  As each individual is different, the benefits, if any, of taking Koios’ products will vary from person to person.  No claims or guarantees can be made as to the effects of Koios’ products on an individual’s health and wellbeing.